Evidence map›Paper›PMID 40419924›Full record

ArticleMedicine2025

Aberrant obturator artery or corona mortis embolization for the treatment of pelvic trauma hemorrhage: Technique and clinical outcomes.

Yook Kim, Eic Ju Lim

Abstract read
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yook KimDepartment of Radiology, Chungbuk National University Hospital, Chugbuk National University College of Medicine, Cheongju, Republic of Korea.
Eic Ju LimDepartment of Orthopaedic Surgery, Chungbuk National University Hospital, Chugbuk National University College of Medicine, Cheongju, Republic of Korea.ORCID 0000-0001-8095-6173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to assess the safety and efficacy of transcatheter arterial embolization (TAE) of the corona mortis in the aberrant obturator artery (AOA) for the management of bleeding in blunt pelvic trauma. This retrospective analysis included data on 14 patients (mean age, 68.6; range, 34-85 years) who underwent TAE of the corona mortis for managing hemorrhage following pelvic fracture from September 2018 to March 2023. Medical records' data included clinical manifestation, injury severity score, hemodynamic stability, length of stay in intensive care unit, transfusion requirement, complications related to the TAE, and clinical outcomes. Of 14 patients that underwent abdominopelvic computed tomography before the TAE, 12 demonstrated positive imaging findings for bleeding including pseudoaneurysm and contrast media extravasation. Thirteen exhibited ipsilateral fracture of the superior ramus fracture, all had a positive sign of bleeding and underwent super-selective TAE of the corona mortis to control the bleeding. Overall, technical success was achieved in all 14. None of the patients demonstrated any procedure-related complications. TAE of the corona mortis is a safe and effective method for controlling hemorrhage following pelvic bone fractures. In particular, fractures involving the superior pubic ramus or pubic acetabulum warrant close attention to bleeding from the AOA, known as the corona mortis.

Indexed as

Embolization, TherapeuticFractures, BoneHemorrhagePelvic BonesWounds, NonpenetratingAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment Outcomeaberrant obturator arterycorona mortisfracturespubic ramustranscatheter arterial embolization

Identifiers

PMID40419924
PMCPMC12113967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.